Inactief instrument

Andere talen Provention Bio, Inc.

Aandelen

PRVB

US74374N1028

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P Pharmaceuticals Select Industry Index	02-05-23
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P Global BMI Index	02-05-23
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from S&P TMI Index	02-05-23
Improving Confidence in Eurozone Economy Lifts French Shares Amid Q1 Results Outpour	27-04-23
Sanofi Completes Provention Bio Acquisition	27-04-23
Sanofi : acquisition de Provention Bio finalisée	27-04-23
Sanofi : finalise l'acquisition de l'américain Provention Bio	27-04-23
Provention Bio : Termination of Material Agreement - Form 8-K	27-04-23
PROVENTION BIO, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	27-04-23
Provention Bio, Inc. Appoints Debora Pellicano as Chief Financial Officer	27-04-23
Provention Bio, Inc. Announces Management Changes	27-04-23
Sanofi a finalisé l'acquisition de la biotech américaine Provention Bio	27-04-23
Sanofi Closes $3 Billion Acquisition of Provention Bio	27-04-23
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from NASDAQ Composite Index	27-04-23
Sanofi completed the acquisition of 97.1% stake in Provention Bio, Inc..	27-04-23
Sanofi : période d'attente expirée pour Provention Bio	26-04-23
Sanofi Secures US Antitrust Clearance for $2.9 Billion Provention Bio Takeover	26-04-23
Provention Bio, Inc.(NasdaqGS:PRVB) dropped from NASDAQ Biotechnology Index	26-04-23
Sanofi wins US drug control from AstraZeneca in Sobi deal	11-04-23
Sanofi Extends Offer Period for Provention Bio Takeover Amid US Regulatory Review	11-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Provention Bio, Inc.

Aandelen

PRVB

US74374N1028

Andere talen

Filters